BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 15501971)

  • 21. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7.
    Pilch H; Hoehn H; Schmidt M; Steiner E; Tanner B; Seufert R; Maeurer M
    Zentralbl Gynakol; 2002; 124(8-9):406-12. PubMed ID: 12655469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
    Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
    Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
    Nemes JA; Deli L; Nemes Z; Márton IJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma.
    Slebos RJ; Yi Y; Ely K; Carter J; Evjen A; Zhang X; Shyr Y; Murphy BM; Cmelak AJ; Burkey BB; Netterville JL; Levy S; Yarbrough WG; Chung CH
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):701-9. PubMed ID: 16467079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer.
    Zehbe I; Kaufmann AM; Schmidt M; Hohn H; Maeurer MJ
    J Immunother; 2007; 30(5):523-32. PubMed ID: 17589293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients.
    Nikitina EY; Clark JI; Van Beynen J; Chada S; Virmani AK; Carbone DP; Gabrilovich DI
    Clin Cancer Res; 2001 Jan; 7(1):127-35. PubMed ID: 11205900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index.
    Azzimonti B; Pagano M; Mondini M; De Andrea M; Valente G; Monga G; Tommasino M; Aluffi P; Landolfo S; Gariglio M
    Histopathology; 2004 Dec; 45(6):560-72. PubMed ID: 15569046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiles in HPV-infected head and neck cancer.
    Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
    J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neck.
    Scheckenbach K; Lieven O; Götte K; Bockmühl U; Zotz R; Bier H; Balz V
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1805-9. PubMed ID: 15533911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients.
    Shi Q; Xiao K; Wei W; Zhang BY; Chen C; Xu Y; Chen LN; Song YT; Ma X; Zhang NS; Dong XP
    Oncol Rep; 2013 Dec; 30(6):2811-9. PubMed ID: 24064928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis.
    Ferris RL; Martinez I; Sirianni N; Wang J; López-Albaitero A; Gollin SM; Johnson JT; Khan S
    Eur J Cancer; 2005 Mar; 41(5):807-15. PubMed ID: 15763658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma.
    Cao J; Zhang ZY; Patima ; Zhang YX; Chen WT
    Chin J Dent Res; 2000 Nov; 3(3):44-9. PubMed ID: 11314535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus infection and p53 nuclear overexpression in anal canal carcinoma.
    Indinnimeo M; Cicchini C; Stazi A; Giarnieri E; French D; Limiti MR; Ghini C; Vecchione A
    J Exp Clin Cancer Res; 1999 Mar; 18(1):47-52. PubMed ID: 10374676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms.
    Bolt J; Vo QN; Kim WJ; McWhorter AJ; Thomson J; Hagensee ME; Friedlander P; Brown KD; Gilbert J
    Oral Oncol; 2005 Nov; 41(10):1013-20. PubMed ID: 16139561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas.
    Hoffmann M; Lohrey C; Hunziker A; Kahn T; Schwarz E
    Oral Oncol; 2004 May; 40(5):520-4. PubMed ID: 15006625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.
    Wiest T; Schwarz E; Enders C; Flechtenmacher C; Bosch FX
    Oncogene; 2002 Feb; 21(10):1510-7. PubMed ID: 11896579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.